OTC · Healthcare · Biotechnology
Hepion Pharmaceuticals, Inc.
HEPA
Hepion Pharmaceuticals, Inc. CEO Gary S. Stetz · Market cap $722K.
$0.06
-0.01 · -14.81%
52w hi $0.2552w lo $0.03
Off 52w high 87.3%
87
STRONG
Current InsiderScore
Corp · 90d
5
5 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
5
3 strong · 2 notable
Analyst consensus
Strong Buy
Avg PT $70.00
Section 01
Recent Form 4 filings
5 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Apr 21 | Michael J. Purcell | Buy | 1,250,000 | $0.04 | +$50K | 73 | |
| Apr 21 | Sireesh Appajosyula | Buy | 1,250,000 | $0.04 | +$50K | 73 | |
| Apr 21 | Vincent S Lopriore | Executive Chairman | Buy | 1,250,000 | $0.04 | +$50K | 75 |
| Apr 21 | Gary S. Stetz | Interim CEO | Buy | 1,250,000 | $0.04 | +$50K | 82 |
| Apr 21 | Vincent S Lopriore | Executive Chairman | Buy | 5,000,000 | $0.04 | +$200K | 87 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay